세계 흉강 배액 장치 시장 – 2023-2030

Global Thoracic Drainage Devices Market -2023-2030

상품코드MD7209
발행기관DataM Intelligence
발행일2023.11.01
페이지 수186 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

개요
전 세계 흉강 배액 장치 시장은 2022년 YY억 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY억 달러에 이를 것으로 예상됩니다. 환자들이 최소 침습적인 시술을 선호하는 추세에 따라 최소 침습 흉강 배액 시술이 증가하는 추세가 전 세계 흉강 배액 장치 시장을 주도할 것으로 전망됩니다.
전 세계 흉강 배액 장치 시장은 최근 몇 년간 크게 성장했으며, 이러한 상승세는 지속될 것으로 예상됩니다. 이 시장은 환자의 실시간 모니터링, 원격 데이터 접근, 향상된 환자 관리를 가능하게 하는 연결 기능을 갖춘 흉강 배액 시스템의 디지털화와 같은 여러 중요한 추세의 영향을 받아 전환기를 맞고 있습니다.

또한, 흉부 질환의 유병률 증가, 흉강 배액 장치의 지속적인 기술 발전으로 효율성과 안전성이 향상되었으며, 폐 절제술 및 이식술을 포함한 흉부 수술 건수 증가로 수술 후 관리에 흉강 배액 장치가 필요한 경우가 늘어나면서 흉강 배액 장치 시장 규모가 성장하고 있습니다. 신기술 연구 활동의 증가와 유력 제약 의료기기 회사의 존재는 북미 지역 수요 증가에 기여하는 요인 중 일부입니다. ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company 등 주요 경쟁업체들이 시장에서 활발하게 활동하고 있습니다.

시장 동향
흉부 수술 건수 증가가 흉강 배액 장치 시장 성장을 견인할 전망
흉부 수술 건수 증가는 흉강 배액 장치 시장 성장을 견인하는 중요한 요인입니다. 이러한 기기들은 심흉부외과 수술에서 필수적인데, 심낭 및 흉막강에서 혈액, 체액, 공기를 배출하여 수술 후 합병증을 줄이고 삼출, 심장압전, 기흉, 출혈과 같은 문제를 최소화하기 때문입니다. 개선된 디지털 배액 장치가 개발되기 전까지 지난 50년 동안 흉부외과 수술에서는 고전적인 3챔버 흡인법이 표준으로 사용되었습니다.
예를 들어, 2022년 미국 국립 의학 도서관(National Library of Medicine)에 발표된 기사에 따르면, 미국에서만 매년 약 4,000명의 심흉부외과 의사가 약 53만 건의 일반 흉부외과 수술을 시행하고 있으며, 이들 중 대다수(92%)는 남성이고 평균 연령은 56세입니다. 평균적인 흉부외과 의사는 연간 135명의 환자를 수술합니다. 이러한 흉부 수술 건수의 증가는 환자 치료 및 결과 개선 측면에서 시장의 성장 잠재력을 보여줍니다.

기술 발전이 흉강 배액 장치 시장 성장을 견인할 것입니다.
첨단 설계가 적용된 흉강 배액 장치의 지속적인 발전이 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2023년 9월 Merit Medical Systems, Inc.는 Aspira 진공 배액병을 출시했습니다. Aspira 배액 시스템은 재발성 및 증상성 흉막 삼출(폐 외부에 체액이 축적되는 현상)과 악성 복수(암으로 인해 복부에 체액이 축적되는 현상) 치료에 사용됩니다.
또한, 재발성 흉막 삼출 및 악성 복수 배액에 대한 Aspira 배액 시스템의 적응증은 입원 치료가 자주 필요한 이 질환들에 있어 최첨단 배액 기술이 환자 치료 및 삶의 질 향상에 얼마나 중요한 역할을 하는지 보여줍니다. 따라서 더 많은 의료기관과 전문가들이 최첨단 솔루션을 도입함에 따라 흉강 배액 장치 시장은 효율성, 정확성 및 환자 결과를 개선하는 기술적 발전에 힘입어 예측 기간 동안 성장할 것으로 예상됩니다.
숙련된 전문가 부족이 시장 성장을 저해할 것입니다.
숙련된 전문가 부족은 이 시장의 주요 제약 요인입니다. 흉강 배액은 여러 분야의 협력이 필요한 고난도 수술 절차이며, 간호사는 흉관 삽입 및 관리에 중요한 역할을 합니다. 그러나 전공의가 삽입한 흉관은 문제가 발생하는 경우가 많아 추가 교육의 필요성이 강조됩니다.
또한 흉관 삽입은 영상의학과 전문의, 폐 전문의 및 흉부외과 전문의가 시행하는 일반적인 시술입니다. 북미방사선학회(RSNA)의 2022년 보고서에 따르면, 유럽 평균 방사선 전문의 수는 인구 10만 명당 13명인 반면, 영국은 8.5명에 불과하여 방사선 전문의 부족 현상이 심각합니다. 이러한 요인으로 인해 향후 시장 성장이 예상됩니다.
세분화 분석
전 세계 흉강 배액 장치 시장은 제품, 재질 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
우수한 효과와 다양한 제품군 덕분에 흉강 배액 시스템 부문이 흉강 배액 장치 시장 점유율의 약 47.2%를 차지했습니다.
흉강 배액 시스템 부문은 향후 흉강 배액 장치 시장을 주도할 것으로 예상됩니다. 이러한 시스템은 심장 수술, 심흉부 수술, 호흡기내과, 중환자 치료 등 다양한 임상 환경에서 흉막 삼출, 기흉, 혈흉, 수술 후 배액과 같은 질환 치료에 널리 사용됩니다.
이 분야는 흉막 부위에서 공기와 체액을 제거하여 폐 재확장을 돕고 합병증을 줄이는 데 효과적인 다양한 흉부 배액 장치의 뛰어난 성능 덕분에 시장을 주도하고 있습니다. 또한 실시간 모니터링과 향상된 환자 관리를 가능하게 하는 디지털 흉부 배액 시스템의 최신 기술 발전은 이러한 시스템의 광범위한 수용에 기여하고 있습니다.
예를 들어, 2022년 7월 Centese, Inc.는 스탠포드 대학교 의료 센터에서 심장 수술용 Thoraguard 디지털 배액 시스템에 대한 최초의 동료 심사 연구 결과를 발표했으며, 이 연구는 Journal of Thoracic and Cardiovascular Surgery Open에 게재되었습니다. 토라가드(Thoraguard)는 사람의 개입 없이 자동으로 막힘을 제거하는 동시에 임상적 의사결정을 지원하고 결과를 개선하기 위해 중요한 생리적 지표를 지속적이고 정확하게 모니터링하는 최초이자 유일한 디지털 흉관 관리 시스템입니다. 또한 심장 수술 중 사용 시 토라가드는 표준 아날로그 흉관에 비해 안전하고 효과적인 것으로 입증되었습니다. 따라서 이러한 요인들로 인해 해당 부문은 예측 기간 동안 시장을 주도할 것으로 예상됩니다.
지역별 시장 점유율
북미는 임상 시험 증가에 힘입어 2022년 시장 점유율의 약 38.2%를 차지했습니다.
북미에서 임상 시험 건수가 증가함에 따라 흉강 배액 장치 시장이 성장세를 보일 것으로 예상됩니다. 임상 시험은 새로운 장치의 안전성과 효능을 판단하는 데 중요한 역할을 합니다. 예를 들어, 오클라호마 대학교는 소아 환자를 대상으로 디지털 흉관 배액 시스템(Thopaz+)과 아날로그 흉관 배액 시스템을 비교하는 임상 시험을 진행하고 있습니다. 이 연구의 목적은 소아 환자에서 디지털(Thopaz+) 및 아날로그(Pleur-evac) 배액 장치의 효능을 평가하는 것입니다. 이 임상 시험은 중재적, 무작위 배정, 대조 연구로, 140명의 환자를 모집할 예정입니다.
또한, 이 연구는 2024년 4월 1일까지 완료될 예정이며, 지금까지 소아 환자를 대상으로 디지털 흉관 배액 시스템과 아날로그 흉관 배액 시스템을 비교하는 전향적 무작위 대조 임상 시험은 없었습니다. 이는 소아 환자에게 디지털 흉관 배액 시스템을 도입했을 때 얻을 수 있는 잠재적 이점을 조사하는 최초의 전향적 무작위 임상 시험이 될 것입니다.
더욱이, 북미 지역에서 만성 질환의 유병률이 증가하고 있는 것도 시장 성장을 견인할 것으로 예상됩니다. 심장 질환 및 폐 질환과 같은 만성 질환은 흉강 배액 장치에 대한 수요를 증가시키는 주요 요인입니다. 인구 고령화와 생활 습관 요인이 증가함에 따라 이러한 만성 질환에 대한 수요도 증가할 것으로 예상됩니다. 만성 질환의 유병률이 증가함에 따라 적절한 흉강 배액 치료에 대한 필요성이 커지고 있습니다. 따라서 위와 같은 요인으로 인해 해당 지역이 예측 기간 동안 시장을 주도할 것으로 예상됩니다.
경쟁 환경
흉강 배액 장치 시장의 주요 글로벌 업체로는 ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, Cardinal Health, Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Teleflex Incorporated, Utah Medical Products, Inc., Vygon SA, Sterimed Group 등이 있습니다.
COVID-19 영향 분석

세계보건기구(WHO)는 2022년 8월 기준 약 5억 8,500만 건의 COVID-19 확진 사례와 약 640만 명의 사망자를 보고했습니다. 그러나 연구에 따르면 흉강 배액 시스템은 COVID-19의 확산을 예방하는 데 중요한 역할을 합니다. COVID-19 환자는 급성 호흡곤란 증후군(ARDS) 발생 위험이 높으며, 이는 적절한 치료를 필요로 합니다. 침습적 기계 환기.
또한, COVID-19 관련 압력 손상은 기흉을 유발하는 경우가 많아 흉관 삽입(흉강 배액술)이 필요합니다. B. Braun, ATMOS MedizinTechnik GmbH & Co. KG, Getinge, Dräger 등 주요 기업들이 소속된 독일 의료 연합(GHA) 회원사들은 2020년 초부터 자사 제품, 특히 흉강 배액 시스템에 대한 전 세계적인 수요가 크게 증가하는 것을 목격했습니다. 혁신적인 의료기기 제조업체인 ATMOS MedizinTechnik GmbH & Co. KG는 COVID-19 팬데믹 상황에서 생명을 구하는 데 배액 시스템과 같은 제품군이 중요한 역할을 한다는 점을 인식하고 증가하는 수요에 맞춰 생산량을 늘렸습니다.
주요 개발 사항
• 2022년 4월 18일, 의료 기술 제조 및 마케팅 분야의 글로벌 리더인 Merit Medical Systems, Inc.는 ReSolve Thoracostomy Tray를 출시한다고 발표했습니다. 이 새로운 트레이에는 흉강 배액술을 시행하는 데 필요한 모든 것이 포함되어 있습니다. 흉강 배액술은 개복 수술을 피하고 흉부에서 체액이나 공기를 배출할 수 있는 최소 침습적 방법입니다.
• 2020년 12월 15일, Medela LLC는 자사의 Thopaz+ 디지털 흉부 배액 및 모니터링 시스템이 다양한 정량적 테스트를 완료하여 필터 시스템이 COVID-19를 유발하는 바이러스인 SARS-CoV-2와 같은 에어로졸화된 바이러스 입자의 통과를 효율적으로 억제함을 입증했다고 발표했습니다.

보고서 구매 이유:

• 제품, 재료 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 흉부 배액 장치 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별하기 위함입니다.

• 모든 세그먼트를 포함한 흉부 배액 장치 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트가 제공됩니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서가 제공됩니다.

• 주요 업체들의 핵심 제품이 포함된 제품 맵핑이 Excel 파일로 제공됩니다.

글로벌 흉부 배수 장치 시장 보고서는 약 53개의 표, 54개의 그림, 그리고 195페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Thoracic Drainage Devices Market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030 growing with a CAGR of YY% during the forecast period 2023-2030. The trend such as the shift towards minimal invasive thoracic drainage procedures driven by patient preference for less invasive techniques is expected to dominate the global thoracic drainage devices market.
The global thoracic drainage devices market has grown significantly in recent years and is projected to continue on its upward trend. The market is undergoing a transformational period, influenced by several significant trends such as digitalization in chest drainage systems equipped with connectivity features allowing real-time monitoring of patients, remote data access, and improved patient management.
Furthermore, the rising prevalence of thoracic diseases, Continuous technological advancements in thoracic drainage devices have improved their efficiency and safety and increasing number of thoracic surgeries, including lung resections and transplantations, that requires thoracic drainage devices for post-operative care are driving up the thoracic drainage devices market size. The growing research activities for new technologies and presence of establish pharmaceutical medtech companies are some of the factors in demand from North American regions. With significant competitors like ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, and others actively operating in the market.
Dynamics
The Increasing Number of Thoracic Surgeries to Drive the Growth of the Thoracic Drainage Devices Market
The increasing number of thoracic surgeries is an important factor driving in the market for thoracic drainage devices. These devices are essential in cardiothoracic surgery because they allow for the drainage of blood, fluids, and air from the pericardial and pleural cavities, reducing post-operative problems and minimizing concerns such as effusions, tamponade, pneumothoraces, and hemorrhage. Prior to the development of improved digital drainage devices, the classic 3-chamber suction technique was the standard in thoracic surgery for the past five decades.
For instance, according to a National Library of Medicine article published in 2022, states that about 530,000 general thoracic surgery cases are performed annually in the U.S alone by approximately 4,000 cardiothoracic surgeons, the majority of them are male (92%), with an average age of 56 years. The average thoracic surgeon performs 135 patients per year. This increase in thoracic procedures emphasizes the market's potential for growth in enhancing patient care and outcomes.
The Advancements in Technologies will Drive the Thoracic Drainage Devices Market Growth
The growing advancements in thoracic drainage devices emcompassing advanced design is expected to drive the market. For instance, in September 2023, Merit Medical Systems, Inc. announced the launch of its Aspira Evacuated Drainage Bottle. The Aspira Drainage System is used to treat recurring and symptomatic pleural effusions (fluid buildup outside the lungs) and malignant ascites (fluid buildup in the abdomen caused by cancer).
Furthermore, the indications for the Aspira Drainage System for draining recurrent pleural effusions and malignant ascites, both of which frequently require in-hospital drainage, show the crucial role of cutting-edge drainage technologies in improving patient care and quality of life. Thus, as more healthcare organizations and professionals adopt cutting-edge solutions, the market for thoracic drainage devices is expected to grow, fueled by technological improvements that improve efficiency, precision, and patient outcomes over the forecast period.
The Lack of Availability of Skilled Professional Will Hamper the Growth of the Market.
The lack of availability of skilled professional is the major restraint for this market. Thoracic drainage is an advanced surgical procedure that requires interdisciplinary collaboration, and nurses play a significant role in chest tube insertion and care. However, chest tubes inserted by resident physicians are frequently associated with problems, emphasizing the need for further training.
Furthermore, chest tube insertion is a common procedure performed by radiologists, pulmonary specialists, and thoracic surgeons. According to the Radiological Society of North America 2022 article, there is a shortage of radiologists in the U.K, since Europe has 13 radiologists per 100,000 people, but the rate in the U.K. is only 8.5 per 100,000. Thus, owing to this factor the market is expected to grow over the forecast period.
Segment Analysis
The global thoracic drainage devices market is segmented based on product, material type, application, end user and region.
Owing to the Better Effectiveness and Variety, the Chest Drainage Systems Segment Accounted for Approximately 47.2% of the Thoracic Drainage Devices Market Share
The chest drainage systems segment is expected to dominate the thoracic drainage device market. These systems are widely used in a variety of clinical settings, including cardiac surgery, cardiothoracic surgery, pulmonology, and critical care, to treat diseases such as pleural effusion, pneumothorax, hemothorax, and post-operative drainage.
This segment's is dominated due to the variety and effectiveness of chest drainage devices in removing air and fluids from the pleural area, hence aiding lung re-expansion and reducing problems. Furthermore, contemporary technological advancements in digital chest drainage systems, which allow for real-time monitoring and enhanced patient management, contribute to their widespread acceptability.
For instance, in July 2022, Centese, Inc. announced the first peer-reviewed study for its Thoraguard digital drainage system for cardiac surgery at Stanford University Medical Center, which was published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the first and only digital chest tube management system that delivers automated clog removal without human intervention while continuously and precisely monitoring vital physiological indicators to support clinical decision-making and enhance outcomes. Furthermore, when utilized during heart surgery, Thoraguard was demonstrated to be safe and efficacious when compared to standard analog chest tubes. Thus, owing to the above factors the segment is expected to dominate over the forecast period.
Geographical Penetration
North America Accounted for Approximately 38.2% of the Market Share in 2022, Owing to the Increasing Number of Clinical Trials
The increasing number of clinical trials in North America is expected to dominate the thoracic drainage device market. Clinical trials play a vital role in determining the safety and efficacy of novel devices. For instance, the University of Oklahoma is conducting a clinical trial comparing the Digital Chest Tube Drainage System (Thopaz+) to the Analog in Pediatric Patients." The purpose of the research is to assess the efficacy of digital (Thopaz+) and analog (Pleur-evac) drainage devices in pediatric patients. The trial is an interventional, randomized, and controlled study that is expected to enroll 140 people.
Furthermore, the study is expected to be finished by April 1, 2024 and there have been no prospective randomized controlled trials comparing digital versus analog chest tube drainage systems in pediatric patients so far. This will be the first prospective randomized trial to look into the possible benefits of adopting a digital chest tube drainage system in pediatric patients.
Moreover, the increasing prevalence of chronic diseases in North America is also expected to drive the market. Chronic diseases such as heart disease and pulmonology disease are significant drivers of demand for thoracic drainage devices. As the population ages and lifestyle factors increase the prevalence of chronic diseases, the need for appropriate thoracic drainage treatments grows. Thus, owing to the above factors the region is expected to dominate over the forecast period.
Competitive Landscape
The major global players in the thoracic drainage devices market include ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, Cardinal Health., Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Teleflex Incorporated, Utah Medical Products, Inc., Vygon SA, Sterimed Group, and among others.
COVID-19 Impact Analysis

The World Health Organization (WHO) reported more roughly 585.0 million confirmed COVID-19 cases as of August 2022, with around 6.4 million recorded deaths. However, research has shown that thoracic drainage systems play an important role in preventing the widespread development of COVID-19. Individuals with COVID-19 are at a higher risk of having acute respiratory distress syndrome (ARDS), which requires invasive mechanical ventilation.
Furthermore, COVID-19-related barotrauma frequently results in pneumothorax, necessitating chest tube insertion (thoracostomy). Furthermore, members of the German Health Alliance (GHA), which include prominent companies such as B. Braun, ATMOS MedizinTechnik GmbH & Co. KG, Getinge, and Dräger, have seen a significant increase in global demand for their products, particularly thoracic drainage systems, since the beginning of 2020. ATMOS MedizinTechnik GmbH & Co. KG, for example, an innovative medical device maker, has increased production to meet increased demand, realizing that product categories such as drainage systems play a critical role in saving lives in the face of the COVID-19 epidemic.
Key Developments
• On April 18, 2022, Merit Medical Systems, Inc., a global leader in the manufacture and marketing of healthcare technologies, stated the launch of the ReSolve Thoracostomy Tray. The new tray includes everything needed to execute a thoracostomy, a minimally invasive method that allows patients to avoid open surgery to drain fluids or air from the chest.
• On December 15, 2020, Medela LLC stated that their Thopaz+ Digital Chest Drainage and Monitoring System completed various quantitative tests demonstrating that its filtration system efficiently inhibits the passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19.
Why Purchase the Report?
• To visualize the global thoracic drainage devices market segmentation based on product, material type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of thoracic drainage devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.
The global thoracic drainage devices market report would provide approximately 53 tables, 54 figures and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Material Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Number of Thoracic Surgeries
4.1.1.2. The Advancements in Technologies
4.1.2. Restraints
4.1.2.1. The Lack of Availability of Skilled Professional
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Chest Drainage Systems*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.2.1. Water Seal Chest Drainage Systems
7.2.2.2. Dry Seal Chest Drainage Systems
7.2.2.3. Digital Chest Drainage Systems
7.3. Thoracic Drainage Kits
7.4. Pleural Drainage Catheters
7.4.1. Thoracentesis Catheters
7.4.2. Paracentesis Catheters
7.4.3. Others
7.5. Trocar Drains
7.6. Others
8. By Material Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.1.2. Market Attractiveness Index, By Material Type
8.2. Silicone*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polyurethane
8.4. Latex
8.5. Other
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cardiac Surgery*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oncology & Pain Management
9.4. Thoracic Surgery & Pulmonology
9.5. General Intensive Care Emergency Medicine
9.6. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgery Centers
10.4. Cardiac Specialty Clinics
10.5. Cardiothoracic Centers
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. ATMOS MedizinTechnik GmbH & Co. K*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Becton, Dickinson and Company
13.3. Cardinal Health.
13.4. Cook Group Incorporated
13.5. Getinge AB
13.6. Sinapi Biomedical
13.7. Teleflex Incorporated
13.8. Utah Medical Products, Inc.
13.9. Vygon SA
13.10. Sterimed Group
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

ATMOS MedizinTechnik GmbH & Co. K, 4. Key Developments, Becton, Dickinson and Company, Cardinal Health., Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Teleflex Incorporated, Utah Medical Products, Inc., Vygon SA, Sterimed Group

표 목록 (Tables)

List of Tables Table 1 Global Thoracic Drainage Devices Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Thoracic Drainage Devices Market Value, By Material Type, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Thoracic Drainage Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Thoracic Drainage Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Thoracic Drainage Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Thoracic Drainage Devices Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Thoracic Drainage Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 8 Global Thoracic Drainage Devices Market Value, By Material Type, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Thoracic Drainage Devices Market Value, By Material Type, 2021-2030 (US$ Million)

Table 10 Global Thoracic Drainage Devices Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Thoracic Drainage Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 12 Global Thoracic Drainage Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Thoracic Drainage Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 14 Global Thoracic Drainage Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Thoracic Drainage Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Thoracic Drainage Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 17 North America Thoracic Drainage Devices Market Value, By Material Type, 2021-2030 (US$ Million)

Table 18 North America Thoracic Drainage Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 19 North America Thoracic Drainage Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 North America Thoracic Drainage Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Thoracic Drainage Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 22 South America Thoracic Drainage Devices Market Value, By Material Type, 2021-2030 (US$ Million)

Table 23 South America Thoracic Drainage Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 24 South America Thoracic Drainage Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 25 South America Thoracic Drainage Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Thoracic Drainage Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 27 Europe Thoracic Drainage Devices Market Value, By Material Type, 2021-2030 (US$ Million)

Table 28 Europe Thoracic Drainage Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 29 Europe Thoracic Drainage Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 30 Europe Thoracic Drainage Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Thoracic Drainage Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Thoracic Drainage Devices Market Value, By Material Type, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Thoracic Drainage Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Thoracic Drainage Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Thoracic Drainage Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Thoracic Drainage Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Thoracic Drainage Devices Market Value, By Material Type, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Thoracic Drainage Devices Market Value, By Application, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Thoracic Drainage Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 40 ATMOS MedizinTechnik GmbH & Co. K: Overview

Table 41 ATMOS MedizinTechnik GmbH & Co. K: Product Portfolio

Table 42 ATMOS MedizinTechnik GmbH & Co. K: Key Developments

Table 43 Becton, Dickinson and Company: Overview

Table 44 Becton, Dickinson and Company: Product Portfolio

Table 45 Becton, Dickinson and Company: Key Developments

Table 46 Cardinal Health.: Overview

Table 47 Cardinal Health.: Product Portfolio

Table 48 Cardinal Health.: Key Developments

Table 49 Cook Group Incorporated: Overview

Table 50 Cook Group Incorporated: Product Portfolio

Table 51 Cook Group Incorporated: Key Developments

Table 52 Getinge AB: Overview

Table 53 Getinge AB: Product Portfolio

Table 54 Getinge AB: Key Developments

Table 55 Sinapi Biomedical: Overview

Table 56 Sinapi Biomedical: Product Portfolio

Table 57 Sinapi Biomedical: Key Developments

Table 58 Teleflex Incorporated: Overview

Table 59 Teleflex Incorporated: Product Portfolio

Table 60 Teleflex Incorporated: Key Developments

Table 61 Utah Medical Products, Inc.: Overview

Table 62 Utah Medical Products, Inc.: Product Portfolio

Table 63 Utah Medical Products, Inc.: Key Developments

Table 64 Vygon SA: Overview

Table 65 Vygon SA: Product Portfolio

Table 66 Vygon SA: Key Developments

Table 67 Sterimed Group: Overview

Table 68 Sterimed Group: Product Portfolio

Table 69 Sterimed Group: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Thoracic Drainage Devices Market Share, By Product, 2022 & 2030 (%)

Figure 3 Global Thoracic Drainage Devices Market Share, By Material Type, 2022 & 2030 (%)

Figure 4 Global Thoracic Drainage Devices Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Thoracic Drainage Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Thoracic Drainage Devices Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Thoracic Drainage Devices Market Y-o-Y Growth, By Product, 2022-2030 (%)

Figure 8 Chest Drainage Systems Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Thoracic Drainage Kits Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Pleural Drainage Catheters Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 11 Trocar Drains Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Others Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 13 Global Thoracic Drainage Devices Market Y-o-Y Growth, By Material Type, 2022-2030 (%)

Figure 14 Silicone Material Type in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Polyurethane Material Type in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Latex Material Type in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 17 Other Material Type in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Global Thoracic Drainage Devices Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 19 Cardiac Surgery Application in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Oncology & Pain Management Application in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Thoracic Surgery & Pulmonology Application in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 22 General Intensive Care Emergency Medicine Application in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 23 Others Application in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 24 Global Thoracic Drainage Devices Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 25 Hospitals End-User in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 26 Ambulatory Surgery Centers End-User in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 27 Cardiac Specialty Clinics End-User in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 28 Cardiothoracic Centers End-User in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 29 Others End-User in Global Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 30 Global Thoracic Drainage Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 31 North America Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 32 Asia-Pacific Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 33 Europe Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 34 South America Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 35 Middle East and Africa Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 36 North America Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 37 North America Thoracic Drainage Devices Market Share, By Product, 2022 & 2030 (%)

Figure 38 North America Thoracic Drainage Devices Market Share, By Material Type, 2022 & 2030 (%)

Figure 39 North America Thoracic Drainage Devices Market Share, By Application, 2022 & 2030 (%)

Figure 40 North America Thoracic Drainage Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 41 North America Thoracic Drainage Devices Market Share, By Country, 2022 & 2030 (%)

Figure 42 South America Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 43 South America Thoracic Drainage Devices Market Share, By Product, 2022 & 2030 (%)

Figure 44 South America Thoracic Drainage Devices Market Share, By Material Type, 2022 & 2030 (%)

Figure 45 South America Thoracic Drainage Devices Market Share, By Application, 2022 & 2030 (%)

Figure 46 South America Thoracic Drainage Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 47 South America Thoracic Drainage Devices Market Share, By Country, 2022 & 2030 (%)

Figure 48 Europe Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 49 Europe Thoracic Drainage Devices Market Share, By Product, 2022 & 2030 (%)

Figure 50 Europe Thoracic Drainage Devices Market Share, By Material Type, 2022 & 2030 (%)

Figure 51 Europe Thoracic Drainage Devices Market Share, By Application, 2022 & 2030 (%)

Figure 52 Europe Thoracic Drainage Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 53 Europe Thoracic Drainage Devices Market Share, By Country, 2022 & 2030 (%)

Figure 54 Asia-Pacific Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 55 Asia-Pacific Thoracic Drainage Devices Market Share, By Product, 2022 & 2030 (%)

Figure 56 Asia-Pacific Thoracic Drainage Devices Market Share, By Material Type, 2022 & 2030 (%)

Figure 57 Asia-Pacific Thoracic Drainage Devices Market Share, By Application, 2022 & 2030 (%)

Figure 58 Asia-Pacific Thoracic Drainage Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 59 Asia-Pacific Thoracic Drainage Devices Market Share, By Country, 2022 & 2030 (%)

Figure 60 Middle East & Africa Thoracic Drainage Devices Market Value, 2021-2030 (US$ Million)

Figure 61 Middle East & Africa Thoracic Drainage Devices Market Share, By Product, 2022 & 2030 (%)

Figure 62 Middle East & Africa Thoracic Drainage Devices Market Share, By Material Type, 2022 & 2030 (%)

Figure 63 Middle East & Africa Thoracic Drainage Devices Market Share, By Application, 2022 & 2030 (%)

Figure 64 Middle East & Africa Thoracic Drainage Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 65 ATMOS MedizinTechnik GmbH & Co. K: Financials

Figure 66 Becton, Dickinson and Company: Financials

Figure 67 Cardinal Health.: Financials

Figure 68 Cook Group Incorporated: Financials

Figure 69 Getinge AB: Financials

Figure 70 Sinapi Biomedical: Financials

Figure 71 Teleflex Incorporated: Financials

Figure 72 Utah Medical Products, Inc.: Financials

Figure 73 Vygon SA: Financials

Figure 74 Sterimed Group: Financials